The largest database of trusted experimental protocols

Anti phospho nf κb p65 93h1

Manufactured by Cell Signaling Technology

The Anti-phospho NF-κB p65 (93H1) is a rabbit monoclonal antibody that detects phosphorylation of the NF-κB p65 subunit at serine 536. It is designed for use in Western blotting applications.

Automatically generated - may contain errors

2 protocols using anti phospho nf κb p65 93h1

1

NF-κB Activation in SHIV-infected RM-PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoplasmic and nuclear protein extracts obtained from RM-PBMCs infected with NF-κB promoter-variant SHIVs and control cells were subjected to western blot analysis and probed with a polyclonal anti-phospho NF-κB p65 (93H1; Cell Signaling Technology, Danvers MA) or monoclonal GAPDH (1D4, ThermoFisher). Appropriate Goat anti mouse or rabbit secondary antibodies were utilized. Enhanced Chemiluminescence (Azure, Dublin CA) was utilized to detect secondary antibody. Azure c600 western blot imaging system was utilized to capture the chemiluminescent signal. Image Studio™ Lite 4.0 Software (LI-COR, Lincoln NE) was utilized to measure band intensities.
+ Open protocol
+ Expand
2

Immunoblotting and Immunohistochemistry Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for immunohistochemistry (IHC) and Western blot analysis: rabbit anti‐CD8+ (ZA‐0508; ZSGB‐Bio, Beijing, China), rabbit anti‐CCL5 (ab9679), and anti‐PDE5 (ab14672) (both from Abcam, Cambridge, UK), mouse anti‐glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) (60004‐1‐Ig) and anti‐β‐tubulin (66240‐1‐Ig) (both from Proteintech Group Inc, Chicago, IL), rabbit anti‐CCND1 (92G2), anti‐STAT5 (9363), anti‐phospho‐STAT5 (9314), anti‐NF‐κB p65 (8242), and anti‐phospho‐NF‐κB p65 (93H1) (all from Cell Signaling Technology, Denver, MA). Recombinant human (rh)CCL5 (278‐RN) and anti‐CCL5 neutralizing antibody (MAB678) were purchased from R&D systems (Minneapolis, MN), tadalafil (S1512) and a PKG inhibitor KT5823 (S4684) were obtained from Selleckchem (Houston, TX), and a PDE5‐insensitive PKG agonist Sp‐8‐Br‐PET‐cGMP was purchased from Biolog (Hayward, CA). All reagents were used in low androgen medium to reproduce the conditions of finasteride treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!